Literature DB >> 14982719

Predictors of circadian sleep-wake rhythm maintenance in elders with dementia.

S C Sullivan1, K C Richards.   

Abstract

Minimal data exists to predict which elders with dementia in nursing homes will maintain circadian sleep-wake rhythms during senescence and which elders with dementia in nursing homes will experience sleep-wake rhythm deterioration. This circadian deterioration is one of the background factors identified in the Needs-driven Dementia-compromised Behavior Model. The objective of this study was to determine predictors of circadian sleep-wake rhythm maintenance in elders with dementia residing in nursing homes. This secondary analysis identifies predictors of maintaining circadian sleep-wake rhythm in a convenience sample of 171 elders with dementia residing in seven nursing homes in the Southern United States. An autocorrelogram of the circadian sleep-wake rhythm for each participant determined whether or not the rhythm had deteriorated. Using measures of depression, cognitive function, physical and psychosocial activity, medications, and sleep apnea, as well as demographic characteristics of the sample, logistic regression determined the best predictors of rhythm maintenance. The best predictors of circadian sleep-wake rhythm maintenance in elders with dementia residing in nursing homes were physical activity (p = 0.00) and psychosocial activity (p = 0.00). The interaction term between these variables was not significant (p = 0.24). These findings suggest that providing meaningful daytime physical and psychosocial activity may assist in maintaining circadian sleep-wake rhythmicity. Additional research is needed to determine if these interventions would improve circadian sleep-wake rhythm in elders with dementia residing in nursing homes.

Entities:  

Mesh:

Year:  2004        PMID: 14982719     DOI: 10.1080/13607860410001649608

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  8 in total

Review 1.  Sex Differences in Insomnia: from Epidemiology and Etiology to Intervention.

Authors:  Sooyeon Suh; Nayoung Cho; Jihui Zhang
Journal:  Curr Psychiatry Rep       Date:  2018-08-09       Impact factor: 5.285

2.  Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial.

Authors:  Susan M McCurry; Kenneth C Pike; Michael V Vitiello; Rebecca G Logsdon; Eric B Larson; Linda Teri
Journal:  J Am Geriatr Soc       Date:  2011-07-28       Impact factor: 5.562

3.  Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease.

Authors:  Glenna A Dowling; Robert L Burr; Eus J W Van Someren; Erin M Hubbard; Jay S Luxenberg; Judy Mastick; Bruce A Cooper
Journal:  J Am Geriatr Soc       Date:  2007-12-07       Impact factor: 5.562

Review 4.  Sleep and Long-Term Care.

Authors:  Lichuan Ye; Kathy C Richards
Journal:  Sleep Med Clin       Date:  2017-11-22

Review 5.  Sleep disorders and their impacts on healthy, dependent, and frail older adults.

Authors:  V Cochen; C Arbus; M E Soto; H Villars; M Tiberge; T Montemayor; C Hein; M F Veccherini; S H Onen; I Ghorayeb; M Verny; L J Fitten; J Savage; Y Dauvilliers; B Vellas
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

Review 6.  Outpatient treatment of sleep disorders in Alzheimer patients.

Authors:  Francisca Magalhães Scoralick; Einstein Francisco Camargos; Marco Polo Dias Freitas; Otávio Toledo Nóbrega
Journal:  Einstein (Sao Paulo)       Date:  2015-05-01

7.  A Systematic Review of Evidence for a Role of Rest-Activity Rhythms in Dementia.

Authors:  Stephen F Smagula; Swathi Gujral; Chandler S Capps; Robert T Krafty
Journal:  Front Psychiatry       Date:  2019-10-30       Impact factor: 4.157

8.  Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer's Patients Treated with Donepezil: Case Series.

Authors:  Leszek Bidzan; Mariola Bidzan
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-06       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.